Venus Concept (Venus Concept) 3-Year EBITDA Growth Rate : 44.50% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Venus Concept 3-Year EBITDA Growth Rate?

Venus Concept's EBITDA per Share for the three months ended in Dec. 2023 was $-1.45.

During the past 3 years, the average EBITDA Per Share Growth Rate was 44.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 52.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Venus Concept was 72.50% per year. The lowest was 3.00% per year. And the median was 45.75% per year.

Competitive Comparison of Venus Concept's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Venus Concept's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Concept's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Concept's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Venus Concept's 3-Year EBITDA Growth Rate falls into.

Venus Concept 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Venus Concept (NAS:VERO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Venus Concept 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Venus Concept's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Concept (Venus Concept) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Concept Inc (NAS:VERO) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

235 Yorkland Boulevard, Suite 900, Toronto, ON, CAN, M2J 4Y8

Website

https://www.venusconcept.com

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Heal, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Executives

Anthony Natale	director	235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Ross Portaro	officer: President Global Sales	235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Michael Willingham Masters	10 percent owner	3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Silva Rajiv De	director, officer: Chief Executive Officer	1400 ATWATER DRIVE, MALVERN PA 19355
Stanley Tyler Hollmig	director	235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Hemanth Jacob Varghese	officer: President/Chief Bus. Officer	330 JOICEY BOULEVARD, TORONTO A6 M5M2W1
Marlin Fund, Limited Partnership	10 percent owner	MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Capital Management Llc	10 percent owner	3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Fund Iii, Limited Partnership	10 percent owner	MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Master Fund Offshore Ii, Lp	10 percent owner	WAYSTONE CORP SV (CAYMAN) LTD, STE 5B201, FL 2, 1 NEXUS WAY, CAMANA BAY, BOX 1344, GRAND CAYMAN E9 KY1-1108
Mss Vc Spv Lp	10 percent owner	C/O MASTERS SPECIAL SITUATIONS, LLC, 3060 PEACHTREE ROAD, NW, STE.1425, ATLANTA GA 30305
Marlin Fund Ii, Limited Partnership	10 percent owner	MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Special Situations, Llc	10 percent owner	3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Penna Domenic Della	officer: Chief Financial Officer	235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Anna Georgiadis	officer: VP, Global HR	235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8